AAAAAA
Results: 126-150/152
Authors:
STRYCKMANS P
MUUS P
MARIE JP
FILLET G
LABAR B
PEETERMANS M
KURSTJENS J
EFIRA A
PAULUS R
ROOZENDAAL K
SCHAAFSMA R
JAKSIC B
FEREMANS W
VERHEST A
BERNIER M
DARDENNE M
SOLBU G
DEWITTE T
ZITTOUN R
SUCIU S
Citation: P. Stryckmans et al., ADULT PH-LEUKEMIA IN ALL-3 EORTC STUDY( ACUTE LYMPHOBLASTIC), Blood, 84(10), 1994, pp. 10000144-10000144
Authors:
ZITTOUN R
MANDELLI F
DEWITTE T
WILLEMZE R
THALER J
HAYAT M
STRYCKMANS P
PEETERMANS M
DARDENNE M
SOLBU G
SUCIU S
Citation: R. Zittoun et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) DURING INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A RANDOMIZED TRIAL FROM EORTC-GIMEMA LEUKEMIA COOPERATIVE GROUPS, Blood, 84(10), 1994, pp. 10000231-10000231
Authors:
FENAUX P
CHASTANG C
CASTAIGNE S
ARCHIMBAUD E
SANZ M
LINK H
GUERCI A
FEGUEUX N
ZITTOUN R
STOPPA AM
TRAYADE P
LAMY T
MALOISEL F
SADOUN A
SANMIGUEL J
VEIL A
RAYON C
CONDE E
FEY M
BORDESSOULE D
GANSER A
BOWEN D
DREYFUS F
HUGUET F
TILLY H
GUY H
AUZANNEAU G
CHOMIENNE C
DEGOS L
Citation: P. Fenaux et al., TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL TRANSRETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CHEMOTHERAPY (CT) - UPDATED RESULTS OF THE EUROPEAN GROUP, Blood, 84(10), 1994, pp. 10000379-10000379
Authors:
DELMER A
AICHENBAUMCYMBALISTA F
TANG R
RAMOND S
FAUSSAT AM
MARIE JP
ZITTOUN R
Citation: A. Delmer et al., OVEREXPRESSION OF CYCLIN-D1 IN CHRONIC B-CELL MALIGNANCIES WITH ABNORMALITY OF CHROMOSOME-11Q13, Blood, 84(10), 1994, pp. 10000455-10000455
Authors:
FAUSSATSUBERVILLE AM
MARIE JP
DELMER A
CADIOU M
ZITTOUN R
Citation: Am. Faussatsuberville et al., IN-VITRO EFFECT OF RGM-CSF ON PROLIFERATION AND MATURATION OF LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 11(1-2), 1993, pp. 99-104
Authors:
BAUDUER F
DELMER A
BLANC MC
DELMASMARSALET B
CADIOU M
RIO B
MARIE JP
ZITTOUN R
Citation: F. Bauduer et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS AND IN ACCELERATED PHASE WITH HIGH-DOSE OR INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDEAND AMSACRINE, Leukemia & lymphoma, 10(3), 1993, pp. 195-200
Authors:
DELMER A
MARIE JP
THEVENIN D
SUBERVILLE AM
ZITTOUN R
Citation: A. Delmer et al., TREATMENT OF RELAPSING AND REFRACTORY ADULT ACUTE MYELOID-LEUKEMIA ACCORDING TO IN-VITRO CLONOGENIC LEUKEMIC-CELL DRUG-SENSITIVITY, Leukemia & lymphoma, 10(1-2), 1993, pp. 67-71
Authors:
MARIE JP
BASTIE JN
COLOMA F
SUBERVILLE AMF
DELMER A
RIO B
DELMASMARSALET B
LEROUX G
CASASSUS P
BAUMELOU E
CATALIN J
ZITTOUN R
Citation: Jp. Marie et al., CYCLOSPORINE-A AS A MODIFIER AGENT IN THE SALVAGE TREATMENT OF ACUTE-LEUKEMIA (AL), Leukemia, 7(6), 1993, pp. 821-824
Authors:
MARIE JP
FAUSSATSUBERVILLE AM
ZHOU DC
ZITTOUN R
Citation: Jp. Marie et al., DAUNORUBICIN UPTAKE BY LEUKEMIC-CELLS - CORRELATIONS WITH TREATMENT OUTCOME AND MDR1 EXPRESSION, Leukemia, 7(6), 1993, pp. 825-831
Authors:
LEGRAND O
MARIE JP
BARDIN C
BEZIE Y
HERMELIN C
HERRMANN JL
CHAST F
ZITTOUN R
Citation: O. Legrand et al., ADVANTAGES OF CONTINUOUS CEFTAZIDIME INFUSIONS IN A PATIENT WITH APLASIA, La Presse medicale, 22(16), 1993, pp. 786-786
Authors:
GABRIEL S
ZITTOUN R
Citation: S. Gabriel et R. Zittoun, HODGKINS-DISEASE, La Presse medicale, 22(15), 1993, pp. 701
Authors:
DELMER A
GARBAN F
LETOURNEAU A
CONARD J
WEISS L
DIEBOLD J
ZITTOUN R
Citation: A. Delmer et al., WALDENSTROMS MACROGLOBULINEMIA WITH PROMINENT SPLENOMEGALY AND MULTIPLE IMMUNE DISORDERS, Haematologica, 78(6), 1993, pp. 408-410
Authors:
RUSSO D
MARIE JP
DELMER A
ZHOU DC
SUBERVILLE AM
BACCARANI M
ZITTOUN R
Citation: D. Russo et al., DNA-TOPOISOMERASE-I AND DNA-TOPOISOMERASE-II - BIOLOGIC FEATURES AND THEIR ROLE IN DRUG-RESISTANCE, Haematologica, 78(4), 1993, pp. 201-207
Authors:
BAUDUER F
RIO B
ZITTOUN R
LECOMPTE T
LECRUBIER C
BIERLING P
Citation: F. Bauduer et al., OXYTETRACYCLINE-INDUCED THROMBOCYTOPENIC PURPURA, American journal of hematology, 43(4), 1993, pp. 333-334
Authors:
SONNEVELD P
DURIE BGM
MARLE JP
LOKHORST HM
SUCIU S
SOLBU G
SCHOESTER M
LOWENBERG B
ZITTOUN R
Citation: P. Sonneveld et al., MODULATION OF MULTIDRUG-RESISTANCE IN REFRACTORY MYELOMA BY CYCLOSPORINE AND ITS NONIMMUNOSUPPRESSIVE ANALOG PSC-833, Experimental hematology, 21(8), 1993, pp. 1117-1117
Authors:
ZHOU DC
MARIE JP
MAISONNEUVE L
FAUSSATSUBERVILLE AM
ZITTOUN R
Citation: Dc. Zhou et al., EFFECT OF DIFFERENTIATING AGENTS ON MODULATION OF MDR1 GENE-EXPRESSION IN MULTIDRUG-RESISTANT HEMATOPOIETIC HL60 DNR CELL-LINE/, Experimental hematology, 21(6), 1993, pp. 779-784
Authors:
RIO B
BAUDUER F
ARRAGO JP
ZITTOUN R
Citation: B. Rio et al., N-TERMINAL PEPTIDE OF TYPE-III PROCOLLAGEN - A MARKER FOR THE DEVELOPMENT OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BMT AND A BASIS FOR DETERMINING THE TIMING OF PROPHYLACTIC HEPARIN, Bone marrow transplantation, 11(6), 1993, pp. 471-472
Authors:
BAUDUER F
RAMOND S
DELMER A
DELMASMARSALET B
VIGUIE F
DADOUNE JP
ZITTOUN R
Citation: F. Bauduer et al., ACUTE MYELOMONOCYTIC LEUKEMIA IN A XYY MAN, Cancer genetics and cytogenetics, 69(2), 1993, pp. 156-157
Authors:
ZITTOUN R
Citation: R. Zittoun, QUALITY-OF-LIFE IN HEMATOLOGICAL MALIGNANCIES WITH BRIEF REFERENCE TOBONE-MARROW TRANSPLANTATION, Leukemia research, 17(9), 1993, pp. 727-731
Authors:
BAUDUER F
DELMER A
IBIASSI JPN
HARDY AC
RYCKMAN N
ZITTOUN R
Citation: F. Bauduer et al., ANAPHYLACTOID REACTION TO TENIPOSIDE - CA UTION IS WARRANTED IN ATOPIC PATIENTS, La Semaine des hopitaux de Paris, 69(29), 1993, pp. 879-880
Authors:
ZITTOUN R
Citation: R. Zittoun, TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA, Nouvelle revue francaise d'hematologie, 35(3), 1993, pp. 161-169
Authors:
MARIE JP
DELMER A
ZHOU DC
RUSSO D
ZITTOUN R
Citation: Jp. Marie et al., PLEIOTROPIC RESISTANCE IN MALIGNANT HEMOPATHIES - THE GENES INVOLVED AND MODULATION, Nouvelle revue francaise d'hematologie, 35(3), 1993, pp. 191-192
Authors:
DELMER A
BAUDUER F
RUSKONEFOURMESTRAUX A
AJCHENBAUMCYMBALISTA F
DELMASMARSALET B
RIO B
MARIE JP
ZITTOUN R
Citation: A. Delmer et al., TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMP HOMAS WITH SHORT INTENSIVE CHEMOTHERAPY (MACOP-B), Bulletin du cancer, 80(9), 1993, pp. 808-815
Authors:
ZITTOUN R
MANDELLI F
WILLEMZE R
DEWITTE T
LABAR B
RESEGOTTI L
FERRINI PR
VISANI G
CARONIA F
STRYCKMANS P
MARMONT A
HAYAT M
UMLAUFT F
ROTOLI B
PEETERMANS M
PAPA G
LEONI P
PETTI MC
DARDENNE M
SOLBU G
VEGNA ML
SUCIU S
Citation: R. Zittoun et al., PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL, Blood, 82(10), 1993, pp. 10000085-10000085
Authors:
AJCHENBAUMCYMBALISTA F
SOLA B
ANDO K
DELMER A
ROMEO PH
ZITTOUN R
GRIFFIN JD
Citation: F. Ajchenbaumcymbalista et al., CONSTITUTIVE EXPRESSION OF CYCLIN D2 UNCOUPLES PROLIFERATION AND DIFFERENTIATION OF MOUSE ERYTHROLEUKEMIA-CELLS, Blood, 82(10), 1993, pp. 10000182-10000182